About the JEMAThe Japan Endometriosis Association (JEMA) was founded in Osaka , Japan in 1994 by Masumi Inui, who has been Representative since its creation, and colleagues.
JEMA is a non-profit organization dedicated to educating, supporting and advocating for women with endometriosis.
We collaborate with women with endometriosis, health professionals, medical corporations, health governmental organizations, various NPO's, endometriosis support groups around the world, and mass medias.
We advocate and achieve many goals on behalf of wellbeing for women with endometriosis at the national levels.
Abolishing membership dues at the end of 2003, we are supported by donations (contributors are called "supporter").
The number of supporters are about 1000.
Our MissionThe Japan Endometriosis Association (JEMA) is a national organization dedicated to supporting women with endometriosis and questing women’s health for women's lifelong wellness (especially endometriosis).
Our Main Purpose
Office and StaffMasumi INUI, Executive Representative
And two administrative staff, and several volunteer staff.
Location: 1-20-2-301, Nippombashi, Chuo-ku, Osaka-City, OSAKA 542-0073
Health Improvement Activities- To bring the standard global medical treatment to Japan
(Promotion of low-dose pill / Correction of GnRH agonists abuse / Promotion of a laparoscopy, etc.)
National Endometriosis Survey
JEMA's Recent Activities and Events- One of our most important activities is improving medical treatment so that we can keep up with the US & European countries
-The promotion of low-dosage contraceptive pill therapy ( with correction of GnRHa abuse)
＊Since 1996, we have participated in five related medical conferences to speech ,discuss and hand out report, etc.
Since the beginning of the 21st century, among other projects supported by us are educating even MDs specializing in endometriosis the effectiveness of pill treatment, and informing patients or society these options by our newsletter or website.
＊Low-dose pills were not approved until September 1999 in Japan.
GnRHa was used repeatedly (2-3 times those of US/EU).
And we have negotiated with MHLW for introduction of contraceptive pill in collaboration with various women's organizations and female Diet members.
＊After September 1999, the use of pills have not spread because MDs hesitated to prescribe pills without insurance coverage, and with lack of knowledge and experiences they even did not recommend to patients.
And so in the autumn of 2002, we undertook project for applying the health insurance coverage with endometriosis.
＊At the end of 2002, we made the first following written request to MHLW:
supplemental NDA to low-dose pills,introduction of new pills, GnRHa abuse correction.
＊Since 2003, we have been in full cooperation with Nobelpharma Co.,Ltd's clinical development of Ortho M for endometriosis.
The product was submitted to MHLW for approval in October 2006.
＊At the same time, Nihon Schering KK (a subsidiary of Schering AG) have started to develop YAZ, the super-low-dosage contraceptive pill for dysmenorrhea in Japan.
They are working on Phase 3 study.
＊In March 7th of 2005, we made the second written request to MHLW, as world cooperation awareness in March.
We discussed with MHLW staff, and petitioned to a female Diet member of Democratic Party .(her remarks are effectively made in Parliament the following month).
＊In March 7th of 2006, we made the 3rd written request to MHLW and discussed with
. Also we uploaded the ESHRE Endometriosis Guideline - Japanese translation on our website.
＊In October 2006, we made the 4th written request to MHLW and discussed with.
＊At the start of February 2007,the modified ESHRE Endometriosis Guideline - Japanese translation was uploaded on our website.
＊ In March 1st of 2007, we made the 5th written request to MHLW and discussed with.
Copyright(C)1999-2020 Japan Endometriosis Association.AllRight Reserved.